Brief: Shoulder Innovations Expects 2025 Revenue Of $42 Million -$44 Million

Shoulder Innovations

09/09/2025 12:28

Repeats to chain to corrected alerts; no changes to text

Overview

Shoulder Innovations Q2 2025 revenue up 33% to $11 mln, driven by implant sales

Net loss widened to $19.2 mln due to preferred stock warrant liability changes

Co completed IPO raising $75 mln, enhancing financial position for growth

Outlook

Shoulder Innovations expects 2025 revenue between $42 mln and $44 mln

Result Drivers

IMPLANT SALES - Revenue growth driven by 34% increase in implant system sales

CUSTOMER EXPANSION - Nearly 50% increase in surgeon customers year-over-year

FINANCIAL POSITION - IPO and convertible notes financing strengthened balance sheet

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 EPS
-$165.53
Q2 Net Income
-$19.20 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for Shoulder Innovations Inc is $18.50, about 14.1% above its September 8 closing price of $15.90

Press Release: ID:nPn6Tb3rJa

 (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)